1. National Medical Device Postmarket Surveillance Plan [Internet],2013
2. National Cancer Institute [Internet],2016
3. Methodological Considerations in Evaluation of Cancer as an Adverse Outcome Associated With Use of Non-Oncological Drugs and Biological Products in the Postapproval Setting; Public Meeting; Request for Comments [Internet],2014
4. North American Association of Central Cancer Registries Standards and Registry Operations [Internet],2016
5. Cancer Registries Amendment Act [Internet],1992